| 2459 |
926: Oxidation, Glutathione |
1115: Increase, ROS |
Aug 5, 2021 |
Aug 5, 2021 |
1 AOP
|
| 864 |
844: Oxidation, Uroporphyrinogen |
846: Accumulation, Highly carboxylated porphyrins |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 865 |
844: Oxidation, Uroporphyrinogen |
845: Inhibition, UROD |
Nov 29, 2016 |
May 30, 2018 |
1 AOP
|
| 1851 |
1595: Oxidation/denatuation of membrane proteins |
1599: Inflammatory events |
Feb 4, 2019 |
Jul 9, 2019 |
1 AOP
|
| 1669 |
1477: OXPHOS, decreased |
40: Mitochondrial ATP production, decreased |
Oct 10, 2017 |
Oct 10, 2017 |
2 AOPs
|
| 1810 |
1477: OXPHOS, decreased |
1562: Decreased Na/K ATPase activity |
Dec 20, 2018 |
Dec 20, 2018 |
1 AOP
|
| 2095 |
1477: OXPHOS, decreased |
1771: Decrease, ATP pool |
Apr 30, 2020 |
Apr 30, 2020 |
1 AOP
|
| 2346 |
1477: OXPHOS, decreased |
1808: Decrease, ATP synthase activity |
Apr 11, 2021 |
Apr 11, 2021 |
None
|
| 2713 |
1477: OXPHOS, decreased |
1392: Increase, Oxidative Stress |
Jul 25, 2022 |
Jul 25, 2022 |
None
|
| 1282 |
1231: Oxidization of biomolecules, Lipid bilayer and cellular proteins |
1215: TRPA1 activation, TRPA1 Receptor |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1285 |
1231: Oxidization of biomolecules, Lipid bilayer and cellular proteins |
1236: Generation of novel epitopes , Antigen presentation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1286 |
1231: Oxidization of biomolecules, Lipid bilayer and cellular proteins |
1234: Production of nerve growth factor , Epithelial irritation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1711 |
1504: p21 (CDKN1A) expression, increase |
1505: Cell cycle, disrupted |
Jan 21, 2018 |
Jul 25, 2018 |
None
|
| 3083 |
896: Parkinsonian motor deficits |
350: Increase, Mortality |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 236 |
209: Peptide Oxidation |
134: Increase, Kupffer cell activation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 764 |
209: Peptide Oxidation |
719: Increase, hepatocellular adenomas and carcinomas |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 765 |
209: Peptide Oxidation |
768: Increase, Cytotoxicity |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 922 |
209: Peptide Oxidation |
177: Increase, Mitochondrial dysfunction |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 923 |
209: Peptide Oxidation |
87: Release, Cytokine |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 932 |
209: Peptide Oxidation |
357: Cholestasis, Pathology |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 948 |
209: Peptide Oxidation |
926: Oxidation, Glutathione |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 980 |
209: Peptide Oxidation |
935: Decrease, GTPCH-1 |
Nov 29, 2016 |
Sep 28, 2017 |
1 AOP
|
| 992 |
209: Peptide Oxidation |
973: Decrease, AKT/eNOS activity |
Nov 29, 2016 |
Oct 16, 2017 |
1 AOP
|
| 1237 |
209: Peptide Oxidation |
1172: Increased activation, Nuclear factor kappa B (NF-kB) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1379 |
209: Peptide Oxidation |
1292: Activation, JNK |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|